Misplaced Pages

You can help expand this article with text translated from the corresponding article in French. (February 2020) Click for important translation instructions. View a machine-translated version of the French article. Machine translation, like DeepL or Google Translate, is a useful starting point for translations, but translators must revise errors as necessary and confirm that the translation is accurate, rather than simply copy-pasting machine-translated text into the English Misplaced Pages. Do not translate text that appears unreliable or low-quality. If possible, verify the text with references provided in the foreign-language article. You must provide copyright attribution in the edit summary accompanying your translation by providing an interlanguage link to the source of your translation. A model attribution edit summary is Content in this edit is translated from the existing French Misplaced Pages article at ]; see its history for attribution. You may also add the template {{Translated|fr|Institut national de la santé et de la recherche médicale}} to the talk page. For more guidance, see Misplaced Pages:Translation.

Institut national de la santé et de la recherche médicale

Abbreviation	Inserm
Formation	1964
Type	Governmental organization
Location	Paris
Region served	France
Official language	French
Director	Claire Giry (interim)
Staff	6,500
Website	inserm.fr/en

The Institut national de la santé et de la recherche médicale (Inserm, French pronunciation: [insɛʁm]) is the French National Institute of Health and Medical Research.

History and organisation

Inserm was created in 1964 as a successor to the French National Institute of Health.

Inserm is the only public research institution solely focused on human health and medical research in France. It is a public institution with a scientific and technical vocation under the dual auspices of the Ministry of Health and the Ministry of Research. Similarly to the US National Institutes of Health, Inserm conducts fundamental and translational research projects through 339 research units, run by around 13,000 scientists, including 5,100 permanent research staff members and 5,100 staff members co-affiliated with university hospitals and medicine faculties. Inserm's laboratories and research units are located all over France, mainly in the largest cities. Eighty percent of Inserm research units are embedded in research hospitals of French universities.

In 1997, Inserm founded Orphanet, a rare disease database.

Inserm's CEO is chosen by decree upon a proposal of the Ministers of Health and Research, advised by a review committee. The CEO since January 2019 is Gilles Bloch, a doctor and researcher specializing in medical imaging.

Ranking

According to the 2019 Scimago Institutions Ranking, Inserm is the second-best research institution in the health sector (behind the NIH) and twenty-second best across all sectors.

Awards

Nobel prizes

Two Inserm research scientists have been awarded by the Nobel Prize in Physiology or Medicine. In 1980, the French immunologist Jean Dausset received the Nobel prize (along with Baruj Benacerraf and George Davis Snell), for his work on the discovery and characterisation of the genes making the major histocompatibility complex. In 2008, the French virologist Françoise Barré-Sinoussi was awarded, together with her former mentor Luc Montagnier, for the identification of the human immunodeficiency virus.

Grand prix de l'Inserm

Each year, Inserm awards three researchers in three major distinct categories. The Grand prix de l'Inserm recognizes major advancements in biology for an active researcher of the institution, the Grand prix d'honneur recognizes a French public institution's researcher whose contributions have had a major impact in science, and the Prix étranger (Foreign Prize) awards a foreign researcher for their particular contributions to biomedical research. In addition the Inserm has internal awards for engineers and young researchers.

Awardees

Notes and references

1. About INSERM n.d., retrieved 16 June 2018.
2. Rath, Ana; Olry, Annie; Dhombres, Ferdinand; Brandt, Maja Miličić; Urbero, Bruno; Ayme, Segolene (May 2012). "Representation of rare diseases in health information systems: The orphanet approach to serve a wide range of end users". Human Mutation. 33 (5): 803–808. doi:10.1002/humu.22078.
3. France may be back, but the old ways persist for INSERM. The Lancet, Volume 391, Issue 10138, p 2390, retrieved 16 June 2018.
4. "Gilles Bloch, Inserm Chairman and Chief Executive Officer, takes office". Inserm. 2019-01-04. Retrieved 2020-12-24.
5. "Scimago Institutions Rankings". www.scimagoir.com. Retrieved 2019-07-26.
6. "Edith Heard, Specialist in Epigenetics, Awarded the 2017 Inserm Grand Prize". Newsroom | Inserm. 2017-11-13. Retrieved 2018-10-09.
7. 2016 Inserm awards laureates on the INSERM website retrieved Dec 4th 2016.
8. Lauréats des prix Inserm 2015 de la recherche médicale on the INSERM website retrieved Nov 23rd 2015.
9. Lauréats des prix Inserm 2014 de la recherche médicale Archived 2016-09-20 at the Wayback Machine on the INSERM website retrieved Dec 14th 2014.
10. Lauréats du Grand Prix 2013 de la recherche médicale Archived 2014-02-08 at the Wayback Machine on the INSERM website retrieved Nov 22nd 2013.
11. Lauréats du Grand Prix 2012 de la recherche médicale Archived 2016-03-05 at the Wayback Machine on the INSERM website retrieved Nov 21st 2012.
12. Lauréats du Grand Prix 2011 de la recherche médicale Archived 2011-12-05 at the Wayback Machine on the INSERM website retrieved Dec 06th 2011.
13. Lauréats du Grand Prix de la recherche médical Archived 2010-12-10 at the Wayback Machine on the INSERM website retrieved Nov 30th 2010
14. Lauréats du Grand Prix de la recherche médical Archived 2010-12-27 at the Wayback Machine on the INSERM website retrieved Nov 24th 2009
15. Lauréats du Grand Prix de la recherche médical on the INSERM website retrieved on Dec 2nd 2008

External links

• Official website (English)

You can help expand this article with text translated from the corresponding article in French. (October 2016) Click for important translation instructions. View a machine-translated version of the French article. Machine translation, like DeepL or Google Translate, is a useful starting point for translations, but translators must revise errors as necessary and confirm that the translation is accurate, rather than simply copy-pasting machine-translated text into the English Misplaced Pages. Consider adding a topic to this template: there are already 1,674 articles in the main category, and specifying|topic= will aid in categorization. Do not translate text that appears unreliable or low-quality. If possible, verify the text with references provided in the foreign-language article. You must provide copyright attribution in the edit summary accompanying your translation by providing an interlanguage link to the source of your translation. A model attribution edit summary is Content in this edit is translated from the existing French Misplaced Pages article at ]; see its history for attribution. You may also add the template {{Translated|fr|Institut national de la santé et de la recherche médicale}} to the talk page. For more guidance, see Misplaced Pages:Translation.

• 1964 establishments in France
• Medical and health organizations based in France
• Scientific organizations based in France
• Inserm
• Public health in France